UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Hydrocortisone for Extubation to Prevent Bronchopulmonary Dysplasia
    Edward F. Bell
  2. Necrotizing Enterocolitis Surgery Trial (NEST)
    Edward F. Bell
  3. Late Hypothermia for Hypoxic-Ischemic Encephalopathy
    Edward F. Bell
  4. Effect of Intravenous α-1 Antitrypsin on Preserving β-cell Function in New-onset Type 1 Diabetes Mellitus
    Eva Tsalikian
  5. Optimizing Cooling for Neonatal Hypoxic-Ischemic Encephalopathy
    Edward F. Bell
  6. Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycemic control in children and adolescents with type 2 diabetes. A 26-week double-blind, randomized,…
    Eva Tsalikian
  7. A Phase I/II, Open Label Study of Ad-RTS-hIL-12, an Adenovirus Vector Engineered to Express hIL-12, in Combination with an Oral Activator Ligand, in Subjects with Unresectable Stage III or IV Melanoma…
    Mohammed Milhem
  8. RTOG 1115: Phase III trial of dose escalated radiation therapy and standard androgen deprivation therapy (ADT) with a GnRH agonist vs. dose...
    Mark C. Smith
  9. A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Ch…
    Alexandra Thomas
  10. Central vs Peripheral Sensitization and the Role of Individual Difference in Acute Myalgia
    Laura Frey Law
  11. In vitro PK studies in prostate cancer for aptamer development
    Daniel Vaena
  12. A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
    John Buatti
  13. A randomized phase II study of Azacitidine in combination with Lenalidomide (NSC-703812) vs Azacitidine alone vs Azacitidine in combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic…
    Thomas Carter
  14. A Phase 2 Study of MLN8237 in Advanced / Metastatic Sarcoma
    Mohammed Milhem
  15. A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
    Ayman El-Sheikh
  16. A Phase II Evaluation of Dalantercept (NSC #757172, IND #116598), A Novel Soluble Recombinant Activin Receptor-Like Kinase 1 (ALK-1) Inhibitor Receptor-Fusion Protein, in the Treatment of Persistent o…
    David Bender
  17. A multi-center, open-label, single-arm, Phase 3b study of macitentan in patients with Pulmonary Arterial Hypertension to psychometrically validate the...
    Linda Cadaret
  18. A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated w
    Alexandra Thomas
  19. A Phase III, Multi-center, Open-label, Randomized, Controlled Study of the Efficacy and Safety of Oral LDE225 Versus Temozolomide in Patients With...
    Sue O Dorsio
  20. Prospective Randomized Phase II Trial of Pazopanib (NSC #737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors
    Nancy Sharma

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.